Key result
Pacing-induced ischemia is linked to a ~60% reduction in perfused myocardial mass demonstrating microcirculatory vasoconstriction.
Why the study?
Does pacing-induced ischemia alter coronary and myocardial blood flow and perfused tissue mass in patients with stable angina and single-vessel coronary disease?
Observational (n=9)
Does pacing-induced ischemia alter coronary and myocardial blood flow and perfused tissue mass in patients with stable angina and single-vessel coronary disease?
The vasoconstrictor response to pacing-induced ischemia is heterogeneously distributed, excluding a tissue fraction from perfusion while metabolic demand controls vasomotor tone in perfused tissue.
Heterogeneous vasoconstriction may limit perfused mass during ischemia in stable angina; leaves open therapeutic or prognostic implications pending prospective trials.
The classical model of coronary physiology implies the presence of maximal microcirculatory vasodilation during myocardial ischemia. However, Doppler monitoring of coronary blood flow (CBF) documented severe microcirculatory vasoconstriction during pacing-induced ischemia in patients with coronary artery disease. This study investigates the mechanisms that underlie this paradoxical behavior in nine patients with stable angina and single-vessel coronary disease who were candidates for stenting. While transstenotic pressures were continuously monitored, input CBF (in ml/min) to the poststenotic myocardium was measured by Doppler catheter and angiographic cross-sectional area. Simultaneously, specific myocardial blood flow (MBF, in ml.min(-1).g(-1)) was measured by 133Xe washout. Perfused tissue mass was calculated as CBF/MBF. Measurements were obtained at baseline, during pacing-induced ischemia, and after stenting. CBF and distal coronary pressure values were also measured during pacing with intracoronary adenosine administration. During pacing, CBF decreased to 64 +/- 24% of baseline and increased to 265 +/- 100% of ischemic flow after adenosine administration. In contrast, pacing increased MBF to 184 +/- 66% of baseline, measured as a function of the increased rate-pressure product (r = 0.69; P < 0.05). Thus, during pacing, perfused myocardial mass drastically decreased from 30 +/- 23 to 12 +/- 11 g (P < 0.01). Distal coronary pressure remained stable during pacing but decreased after adenosine administration. Stenting increased perfused myocardial mass to 39 +/- 23 g (P < 0.05 vs. baseline) as a function of the increase in distal coronary pressure (r = 0.71; P < 0.02). In conclusion, the vasoconstrictor response to pacing-induced ischemia is heterogeneously distributed and excludes a tissue fraction from perfusion. Within perfused tissue, the metabolic demand still controls the vasomotor tone.
No takes yet. Share an insight, caveat, or question.
Sambuceti et al. (2005) conducted an observational in stable angina and single-vessel coronary disease (n=9). Pacing-induced ischemia vs. Baseline was evaluated on Perfused myocardial mass (p=<0.01). Pacing-induced ischemia drastically decreased perfused myocardial mass from 30 g at baseline to 12 g (P<0.01), demonstrating heterogeneous microcirculatory vasoconstriction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: